IHS Chemical Week

Chemical Week Magazine :: New Construction Projects

GSK Builds Biopharmaceutical Manufacturing Facility in the U.K.

5:57 AM MDT | April 6, 2012

GlaxoSmithKline (GSK) has confirmed plans, originally outlined in 2010, to invest more than £500 million ($799 million) in R&D and manufacturing in the U.K. GSK will invest £350 million of the total to build a biopharmaceutical manufacturing facility at the company’s Ulverston site. It will be the first new manufacturing plant to be built by GSK in the U.K. for 40 years. The company will also spend £100 million of the total at its existing manufacturing operations at Montrose and Irvine. GSK will invest the remaining £50 million in early-stage...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa